The story of Ziam refuses to rush. It stretches tension across every corridor and back alley. Crowds scramble for clean water, families shatter under pressure, and a city already dying starts to split ...

For years, scientists have believed that inflammation inevitably increases with age, quietly fuelling diseases like heart ...

Humidity, excessive moisture, and heat—all these are breeding grounds of bacteria-borne illnesses. In such weather conditions ...

Africa Check has debunked viral social media claims about an HIV “cure”, clarifying that the breakthrough is promising, but ...

Browse 50+ infectious erythema stock illustrations and vector graphics available royalty-free, or start a new search to explore more great stock images and vector art. Preventing tick bite and lyme ...

As the search continues for Travis Decker more than a month after the murder suspect vanished, a local sheriff has a new ...

Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.

During image pair learning sessions, positive emotions promoted brain activity that could predict how well participants ...

Chronic wounds affect millions of people worldwide. These are cuts, burns, scrapes, or surgical wounds that don’t heal within ...

Data from the Phase 3, multicenter, single-arm prospective study evaluating the safety and efficacy of Mavyret eight-week treatment in adults with acute HCV infection supported the label expansion.

In 2017, the FDA approved Mavyret to treat adults with chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infections without cirrhosis or with compensated cirrhosis.